Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion
1999 ◽
Vol 18
(3)
◽
pp. 223-231
◽
1996 ◽
Vol 15
(12)
◽
pp. 1059-1068
◽
2000 ◽
Vol 83
(4)
◽
pp. 313-316
◽
2011 ◽
Vol 53
(3)
◽
pp. 368-373
◽
2007 ◽
Vol 179
(5)
◽
pp. 3171-3177
◽
2002 ◽
Vol 38
(6)
◽
pp. 550-554
◽